Abeona Therapeutics Inc.
ABEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $286,400 | $298,339 | $236,948 | $228,637 |
| - Cash | $83,222 | $163,535 | $15,936 | $23,357 |
| + Debt | $24,107 | $24,076 | $23,977 | $23,048 |
| Enterprise Value | $227,285 | $158,880 | $244,989 | $228,328 |
| Revenue | $0 | $400 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$488 | $300 | $0 | -$776 |
| % Margin | – | 75% | – | – |
| EBITDA | -$18,569 | $126,070 | -$10,216 | -$7,437 |
| % Margin | – | 31,517.5% | – | – |
| Net Income | -$5,161 | $108,833 | -$12,029 | -$9,293 |
| % Margin | – | 27,208.3% | – | – |
| EPS Diluted | -0.1 | 1.71 | -0.24 | -0.23 |
| % Growth | -105.8% | 812.5% | -4.3% | – |
| Operating Cash Flow | -$21,187 | -$18,784 | -$18,402 | -$16,559 |
| Capital Expenditures | -$2,520 | -$2,901 | -$1,401 | -$606 |
| Free Cash Flow | -$23,707 | -$21,685 | -$19,803 | -$17,165 |